| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 07/13/2005 | EP1551803A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 07/13/2005 | EP1551802A1 Indole-3-sulphur derivatives |
| 07/13/2005 | EP1551795A1 Inhibitors of histone deacetylase |
| 07/13/2005 | EP1551406A1 Use of indolyl derivatives for the manufacture of a medicament for the treatment of allergic rhinitis |
| 07/13/2005 | EP1161415B1 N-cyanomethylamides as protease inhibitors |
| 07/13/2005 | EP1113795B1 Tryptophanyl esters and their n-acyl derivatives for the prevention and treatment of diseases caused or exacerbated by oxidation processes |
| 07/13/2005 | EP0938308B1 Antiparasitic agents |
| 07/13/2005 | CN1639122A Azaspiro compounds for the treatment of pain |
| 07/13/2005 | CN1639121A 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity |
| 07/13/2005 | CN1639120A Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
| 07/13/2005 | CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 07/13/2005 | CN1639096A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 07/13/2005 | CN1638810A Near infrared fluorescent contrast agent and method for fluorescence imaging |
| 07/13/2005 | CN1638762A Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
| 07/13/2005 | CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 07/13/2005 | CN1638633A Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides |
| 07/13/2005 | CN1637149A Novel use |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636983A Substituted heterocyclic compounds |
| 07/13/2005 | CN1636976A Mutilin derivatives and their use as antibacterials |
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/13/2005 | CN1636566A Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 07/13/2005 | CN1210274C Piperazine and piperidine derivatives |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/13/2005 | CN1210260C Crystalline forms of fluvastatin sodium |
| 07/12/2005 | US6916957 Antiinflammatory agents; antihistamines; antiallergens |
| 07/12/2005 | US6916947 Forming 8-aminooctanoic acid hydrochloride by reacting halogenated carboxylic acid ester with metal cyanate and alcohol, then saponifying |
| 07/12/2005 | US6916922 Acylating a cyclopentaindolemethylamine and cyclizing and reducing the product |
| 07/12/2005 | US6916841 Inhibitors of phospholipase enzymes |
| 07/12/2005 | US6916840 Spla2 inhibitors |
| 07/12/2005 | US6916812 Dietetic agents |
| 07/12/2005 | US6916797 α-arylethylpiperazine derivatives as neurokinin antagonists |
| 07/12/2005 | CA2238859C Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/07/2005 | WO2005061483A2 Modulators of peripheral 5-ht receptors |
| 07/07/2005 | WO2005061477A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | WO2005061475A2 Ornithine derivatives as prostaglandin e2 agonists or antagonists |
| 07/07/2005 | WO2005061455A1 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 07/07/2005 | WO2005061448A1 Compositions and methods for treating vascular conditions |
| 07/07/2005 | WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | WO2005040115A8 Process for the preparation of ropinirole |
| 07/07/2005 | WO2005035495A3 Fibrinogen receptor antagonists and their use |
| 07/07/2005 | US20050148779 Carvedilol monocitrate monohydrate |
| 07/07/2005 | US20050148770 Synthetic methodology for the reductive alkylation at the C-3 position of indoles |
| 07/07/2005 | US20050148656 Carboxylic derivates |
| 07/07/2005 | US20050148651 Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-[ring fused indol-5-yl-(amine- derived)] compounds and analogues thereof, and to products obtained therefrom |
| 07/07/2005 | US20050148648 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators |
| 07/07/2005 | US20050148635 3-imino-2-indolones for the treatment of depression and/or anxiety |
| 07/07/2005 | US20050148631 Modulation of steroid enzymes in mammals as antidiabetic agents, for treatment of obesity, vision defects, lowering fats in blood, for treatment of osteoporosis, tuberculosis or atherosclerosis in mammals |
| 07/07/2005 | US20050148629 Hydroxyamidealkylsulfonamide compounds for anthrax treatment |
| 07/07/2005 | US20050148595 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 07/07/2005 | US20050148584 N-(3-(2-(4-morpholino)ethyloxy)phenyl)-N-{(cis3-(benzylamino)cyclohexyl)methyl}-N'-phenylurea; useful for the treatment of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 07/07/2005 | US20050148578 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 07/07/2005 | US20050147633 Insecticidal amides with nitrogen-containing benzo-Fused bicyclic ring systems |
| 07/07/2005 | DE10356717A1 Verfahren zur Herstellung von (3-Oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-Derivaten A process for the preparation of (3-oxo-2,3-dihydro-1H-isoindol-1-yl) -acetylguanidin derivatives |
| 07/07/2005 | CA2550958A1 Ornithine derivatives as prostaglandin e2 agonists or antagonists |
| 07/07/2005 | CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | CA2548518A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | CA2548494A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 07/07/2005 | CA2547814A1 Spiropiperidine derivatives for controlling pests |
| 07/06/2005 | EP1550655A1 Bicyclic intermediates |
| 07/06/2005 | EP1549685A1 Novel nitrosation polymer in organic synthesis |
| 07/06/2005 | EP1549637A1 1- (indol-3-yl)carbonyl piperazine derivatives |
| 07/06/2005 | EP1549634A1 Novel substituted indoles |
| 07/06/2005 | EP1549614A2 Vasculostatic agents and methods of use thereof |
| 07/06/2005 | EP1549613A1 Sulfonamides having antiangiogenic and anticancer activity |
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | EP1549306A1 Substituted phenylsulfonamide inhibitors of beta amyloid production |
| 07/06/2005 | EP1212320B1 Phenylpiperazines as serotonin reuptake inhibitors |
| 07/06/2005 | CN1636004A Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives |
| 07/06/2005 | CN1635885A Improvement of nitric oxide synthase activity by using substituted indole compound |
| 07/06/2005 | CN1634886A Carbazyl dithio formate RAFT reagent and its preparation method and use |
| 07/06/2005 | CN1634885A Novel mitiglinide crystalline form and its preparing process |
| 07/06/2005 | CN1634864A 9, 9-bis(triphenyl amino) fluorine derivatives and preparation and use thereof |
| 07/06/2005 | CN1209107C Carbazolyl alkaloid anticarcinogen and its prepn |
| 07/05/2005 | US6914145 Acylation process |
| 07/05/2005 | US6914070 Ophthalmic compositions for treating ocular hypertension |
| 07/05/2005 | US6914064 1,4-Disubstituted piperazine derivatives useful as uro-selective α1-adrenoceptor blockers |
| 07/05/2005 | US6913743 Near infrared imaging agent |
| 07/05/2005 | CA2220509C Fused polycyclic heterocycle derivatives |
| 07/05/2005 | CA2151377C Aminomethylindans, -benzofurans and -benzothiophenes |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058868A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 06/30/2005 | WO2005058821A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 06/30/2005 | WO2005058820A1 A synthetic methodology for the reductive alkylation at the c-3 position of indoles |
| 06/30/2005 | WO2005058819A2 Polymorphic forms of tegaserod base and salts thereof |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005030148A3 Tetrahydroindolone derivatives for treatment of neurological conditions |
| 06/30/2005 | WO2004075847A3 METHODS AND COMPOUNDS FOR THE TREATMENT OF Aß ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS |
| 06/30/2005 | US20050143579 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143443 4-substituted pyrrole-2-carboxylic acidsand 5-substituted pyrazole-3-carboxylic acids/esters/salts; increase D-Serine level; reduce level of toxic products of D-Serine oxidation; activate N-methyl-D-aspartate NMDA-glutamate receptors; neuropathic agent, schizophrenia, Alzheimer's, anaxia |
| 06/30/2005 | US20050143427 treating bone disorders of joint cartilage damage, osteoarthritis, rheumatoid arthritis, or joint inflammation, and pain associate with; antiinflammatory agent; 1-methyl-octahydroindole-2-carboxylic acid |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 06/30/2005 | US20050143407 Process for porducing quinolonecarboxylic acid derivative |
| 06/30/2005 | US20050143385 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/30/2005 | US20050143371 Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors |
| 06/30/2005 | US20050143355 Pharmaceutically active salts and esters of 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol and 3- (3-dimethylamino-1-ethyl-1-hydroxy-2-methylpropyl)-phenol and methods of using same |